Affiliation:
1. Diabetes and Endocrine Treatment Specialists , Sandy, UT , USA
Abstract
Abstract
Monogenetic diabetes mellitus (DM) describes a collection of single-gene diseases marked by hyperglycemia presenting in childhood or adulthood and the absence of immunological markers of type 1 DM. Mutations in the human insulin gene INS give rise to two separate clinical syndromes: permanent neonatal DM, type 4 (PNDM4), and maturity-onset diabetes of youth, type 10 (MODY10); the former presents shortly after birth and the latter presents in childhood and adulthood. We describe a 40-year-old man in a kindred with high prevalence of DM who presented with severe hyperglycemia but not ketoacidosis or hypertriglyceridemia. Twelve years after initial presentation, the patient had elevated proinsulin and normal plasma C-peptide when nearly euglycemic on treatment with insulin glargine. A novel INS mutation, Gln65Arg, within the C-peptide region was identified. The INS (p.Gln65Arg) mutation may cause MODY10 by disrupting proinsulin maturation.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Reference13 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016;D 2016 Disease and Injury Incidence and Prevalence Collaborators.;Lancet.,2017
2. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025;Lin;Sci Rep.,2020
3. Pathogenic variants in actionable MODY genes are associated with type 2 diabetes;Bonnefond;Nat Metab.,2020
4. Insulin gene mutations as a cause of permanent neonatal diabetes;Støy;Proc Natl Acad Sci USA.,2007
5. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes;Molven;Diabetes.,2008